3frg: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
[[Image:3frg.png|left|200px]] | |||
[[Image:3frg. | |||
{{STRUCTURE_3frg| PDB=3frg | SCENE= }} | {{STRUCTURE_3frg| PDB=3frg | SCENE= }} | ||
===Catalytic Domain of Human Phosphodiesterase 4B2B in Complex with a Quinoline Inhibitor=== | ===Catalytic Domain of Human Phosphodiesterase 4B2B in Complex with a Quinoline Inhibitor=== | ||
{{ABSTRACT_PUBMED_19195882}} | {{ABSTRACT_PUBMED_19195882}} | ||
==About this Structure== | ==About this Structure== | ||
[[3frg]] is a 1 chain structure of [[Phosphodiesterase]] with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3FRG OCA]. | |||
==See Also== | |||
*[[Phosphodiesterase|Phosphodiesterase]] | |||
==Reference== | ==Reference== | ||
<ref group="xtra">PMID: | <ref group="xtra">PMID:019195882</ref><references group="xtra"/> | ||
[[Category: 3',5'-cyclic-nucleotide phosphodiesterase]] | [[Category: 3',5'-cyclic-nucleotide phosphodiesterase]] | ||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
[[Category: Neu, M.]] | [[Category: Neu, M.]] | ||
[[Category: Somers, D O.]] | [[Category: Somers, D O.]] | ||
[[Category: Camp]] | [[Category: Camp]] | ||
[[Category: Hydrolase]] | [[Category: Hydrolase]] | ||
[[Category: Hydrolase | [[Category: Hydrolase-hydrolase inhibitor complex]] | ||
[[Category: Pde]] | [[Category: Pde]] | ||
[[Category: Phosphodiesterase]] | [[Category: Phosphodiesterase]] | ||
[[Category: Phosphoprotein]] | [[Category: Phosphoprotein]] | ||
Revision as of 05:18, 26 July 2012
Catalytic Domain of Human Phosphodiesterase 4B2B in Complex with a Quinoline Inhibitor
Template:ABSTRACT PUBMED 19195882
About this Structure
3frg is a 1 chain structure of Phosphodiesterase with sequence from Homo sapiens. Full crystallographic information is available from OCA.
See Also
Reference
- Lunniss CJ, Cooper AW, Eldred CD, Kranz M, Lindvall M, Lucas FS, Neu M, Preston AG, Ranshaw LE, Redgrave AJ, Ed Robinson J, Shipley TJ, Solanke YE, Somers DO, Wiseman JO. Quinolines as a novel structural class of potent and selective PDE4 inhibitors: optimisation for oral administration. Bioorg Med Chem Lett. 2009 Mar 1;19(5):1380-5. Epub 2009 Jan 19. PMID:19195882 doi:10.1016/j.bmcl.2009.01.045